Shah Gaurav 内部人交易：近期 SEC Form 4 交易
过去 18 个月，Shah Gaurav（CIK 1725922）在 1 家公司共报告 13 笔 SEC Form 4 内部人交易（最近一笔 2026-08-20）。
| 日期 | 公司 | 身份 | 类型 | 股数 | 市值 |
|---|---|---|---|---|---|
| 2026-08-20 | ROCKET PHARMACEUTICALS, INC. (RCKT) | CEO | 卖出 | 2,293 | $7,753 |
| 2026-08-17 | ROCKET PHARMACEUTICALS, INC. (RCKT) | CEO | 卖出 | 2,837 | $9,592 |
| 2026-05-26 | ROCKET PHARMACEUTICALS, INC. (RCKT) | CEO | 买入 | 76,490 | $129,268 |
| 2026-05-26 | ROCKET PHARMACEUTICALS, INC. (RCKT) | CEO | 卖出 | 55,684 | $172,064 |
| 2026-05-21 | ROCKET PHARMACEUTICALS, INC. (RCKT) | CEO | 卖出 | 2,409 | $7,251 |
| 2026-05-14 | ROCKET PHARMACEUTICALS, INC. (RCKT) | CEO | 卖出 | 2,728 | $9,848 |
| 2026-02-20 | ROCKET PHARMACEUTICALS, INC. (RCKT) | CEO | 卖出 | 5,990 | $20,007 |
| 2026-02-18 | ROCKET PHARMACEUTICALS, INC. (RCKT) | CEO | 卖出 | 12,279 | $40,643 |
| 2026-02-13 | ROCKET PHARMACEUTICALS, INC. (RCKT) | CEO | 买入 | 286,028 | $0 |
| 2025-11-20 | ROCKET PHARMACEUTICALS, INC. (RCKT) | CEO | 卖出 | 6,276 | $18,702 |
| 2025-08-20 | ROCKET PHARMACEUTICALS, INC. (RCKT) | CEO | 卖出 | 2,234 | $6,814 |
| 2025-05-22 | ROCKET PHARMACEUTICALS, INC. (RCKT) | CEO | 卖出 | 2,253 | $14,532 |
| 2025-05-20 | ROCKET PHARMACEUTICALS, INC. (RCKT) | CEO | 卖出 | 3,621 | $23,645 |
来源：SEC Form 4 申报文件 · 截至 2026-08-20